(Q38086608)

28 August 2017

title

Fasudil and its analogs: a new powerful weapon in the long war against central nervous system disorders? (English)

1 reference

28 August 2017

Meihui Chen

1

1 reference

28 August 2017

Anmin Liu

2

1 reference

28 August 2017

Ying Ouyang

3

1 reference

28 August 2017

Yingjuan Huang

4

1 reference

28 August 2017

Xiaojuan Chao

5

1 reference

28 August 2017

Rongbiao Pi

6

1 reference

28 August 2017

language of work or name

English

0 references

publication date

5 March 2013

1 reference

Expert Opinion on Investigational Drugs

28 August 2017

published in

1 reference

28 August 2017

volume

22

1 reference

28 August 2017

issue

4

1 reference

28 August 2017

page(s)

537-550

1 reference

Neuroproteomics approach and neurosystems biology analysis: ROCK inhibitors as promising therapeutic targets in neurodegeneration and neurotrauma

28 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2013.778242

Why do we need multifunctional neuroprotective and neurorestorative drugs for Parkinson's and Alzheimer's diseases as disease modifying agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2013.778242

Rho and Rac take center stage

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2013.778242

Rho-kinase inhibitors as therapeutics: from pan inhibition to isoform selectivity

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2013.778242

The p160 RhoA-binding kinase ROK alpha is a member of a kinase family and is involved in the reorganization of the cytoskeleton

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2013.778242

The therapeutic effects of Rho-ROCK inhibitors on CNS disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2013.778242

Rho kinase inhibitor Fasudil induces neuroprotection and neurogenesis partially through astrocyte-derived G-CSF.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2013.778242

Increased dendrite branching in AbetaPP/PS1 mice and elongation of dendrite arbors by fasudil administration

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2013.778242

Distinct distribution and localization of Rho-kinase in mouse epithelial, muscle and neural tissues

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2013.778242

Rho GTPases and signaling networks

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2013.778242

GEF means go: turning on RHO GTPases with guanine nucleotide-exchange factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2013.778242

Rho-kinase inhibition: a novel therapeutic target for the treatment of cardiovascular diseases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2013.778242

Fasudil, a Rho kinase (ROCK) inhibitor, protects against ischemic neuronal damage in vitro and in vivo by acting directly on neurons

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2013.778242

Stimulation of norepinephrine transporter function by fasudil, a Rho kinase inhibitor, in cultured bovine adrenal medullary cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2013.778242

Physiological role of ROCKs in the cardiovascular system

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2013.778242

Rho kinase as a therapeutic target in cardiovascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2013.778242

Activation of Rho-associated coiled-coil protein kinase 1 (ROCK-1) by caspase-3 cleavage plays an essential role in cardiac myocyte apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2013.778242

Caspase-3-mediated cleavage of ROCK I induces MLC phosphorylation and apoptotic membrane blebbing

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2013.778242

Specific activation of LIM kinase 2 via phosphorylation of threonine 505 by ROCK, a Rho-dependent protein kinase

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2013.778242

Regulation of myosin phosphatase by Rho and Rho-associated kinase (Rho-kinase)

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2013.778242

Rocks: multifunctional kinases in cell behaviour

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2013.778242

Rho-ROCK-LIMK-cofilin pathway regulates shear stress activation of sterol regulatory element binding proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2013.778242

Phosphorylation of myosin-binding subunit (MBS) of myosin phosphatase by Rho-kinase in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2013.778242

ROCK-I and ROCK-II, two isoforms of Rho-associated coiled-coil forming protein serine/threonine kinase in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2013.778242

Rho kinase, a promising drug target for neurological disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2013.778242

Progress of the study of rho-kinase and future perspective of the inhibitor

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2013.778242

Targeted disruption of the mouse rho-associated kinase 2 gene results in intrauterine growth retardation and fetal death

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2013.778242

ROCK-I regulates closure of the eyelids and ventral body wall by inducing assembly of actomyosin bundles

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2013.778242

ROCK-I and ROCK-II cooperatively regulate closure of eyelid and ventral body wall in mouse embryo

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2013.778242

Rho kinase in the regulation of cell death and survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2013.778242

Rho-kinase: important new therapeutic target in cardiovascular diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2013.778242

Comparative gene expression profiling in three primary human cell lines after treatment with a novel inhibitor of Rho kinase or atorvastatin

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2013.778242

Safe and efficient drug delivery system with liposomes for intrathecal application of an antivasospastic drug, fasudil

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2013.778242

Protein kinase G-I deficiency induces pulmonary hypertension through Rho A/Rho kinase activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2013.778242

Simultaneous quantitative analysis of fasudil and its active metabolite in human plasma by liquid chromatography electro-spray tandem mass spectrometry

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2013.778242

Rho-kinase inhibitors Y-27632 and fasudil prevent agonist-induced vasospasm in human radial artery

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2013.778242

Inhibition of Rho-kinase attenuates endothelial-leukocyte interaction during ischemia-reperfusion injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2013.778242

Synergistic effects of bone marrow stromal cells and a Rho kinase (ROCK) inhibitor, fasudil on axon regeneration in rat spinal cord injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2013.778242

Retinal arteriolar responses to acute severe elevation in systemic blood pressure in cats: role of endothelium-derived factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2013.778242

Fasudil improves the endothelial dysfunction in the aorta of spontaneously hypertensive rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2013.778242

Rho-kinase inhibition improves vasodilator responsiveness during hyperinsulinemia in the metabolic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2013.778242

Efficacy and safety of fasudil in patients with subarachnoid hemorrhage: final results of a randomized trial of fasudil versus nimodipine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2013.778242

Antivasospastic effects of hydroxyfasudil, a Rho-kinase inhibitor, after subarachnoid hemorrhage.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2013.778242

Applications for ROCK kinase inhibition

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2013.778242

Current therapies in ischemic stroke. Part A. Recent developments in acute stroke treatment and in stroke prevention

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2013.778242

Basic advances and new avenues in therapy of spinal cord injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2013.778242

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2013.778242

Protective effects of cold spinoplegia with fasudil against ischemic spinal cord injury in rabbits

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2013.778242

Effect of fasudil, a selective inhibitor of Rho kinase activity, in the secondary injury associated with the experimental model of spinal cord trauma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2013.778242

A possible role of RhoA/Rho-kinase in experimental spinal cord injury in rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2013.778242

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2013.778242

Strategies for disease modification in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2013.778242

Changes in hippocampal synapses and learning-memory abilities in a streptozotocin-treated rat model and intervention by using fasudil hydrochloride.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2013.778242

Priorities in Parkinson's disease research

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2013.778242

Inhibition of rho kinase enhances survival of dopaminergic neurons and attenuates axonal loss in a mouse model of Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2013.778242

Involvement of microglial RhoA/Rho-kinase pathway activation in the dopaminergic neuron death. Role of angiotensin via angiotensin type 1 receptors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2013.778242

Impact of behavioral control on the processing of nociceptive stimulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2013.778242

Intratrigeminal ganglionic injection of LPA causes neuropathic pain-like behavior and demyelination in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2013.778242

Characterization of Fasudil in preclinical models of pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2013.778242

Involvement of Rho-kinase in inflammatory and neuropathic pain through phosphorylation of myristoylated alanine-rich C-kinase substrate (MARCKS).

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2013.778242

Xavier Montalban: a pioneer in understanding multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2013.778242

Fasudil ameliorates disease progression in experimental autoimmune encephalomyelitis, acting possibly through antiinflammatory effect

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2013.778242

Rho kinase (ROCK) inhibitors and their application to inflammatory disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2013.778242

A proposed diagnostic scheme for people with epileptic seizures and with epilepsy: report of the ILAE Task Force on Classification and Terminology

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2013.778242

Epileptic seizures and epilepsy: definitions proposed by the International League Against Epilepsy (ILAE) and the International Bureau for Epilepsy (IBE)

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2013.778242

Antiepileptic effects of two Rho-kinase inhibitors, Y-27632 and fasudil, in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2013.778242

Protein kinase A in complex with Rho-kinase inhibitors Y-27632, Fasudil, and H-1152P: structural basis of selectivity

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2013.778242

Conjugates of 5-isoquinolinesulfonylamides and oligo-D-arginine possess high affinity and selectivity towards Rho kinase (ROCK).

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2013.778242

The novel and specific Rho-kinase inhibitor (S)-(+)-2-methyl-1-[(4-methyl-5-isoquinoline)sulfonyl]-homopiperazine as a probing molecule for Rho-kinase-involved pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2013.778242

Development of specific Rho-kinase inhibitors and their clinical application

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2013.778242

Design and synthesis of rho kinase inhibitors (III).

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2013.778242

Designing drugs with multi-target activity: the next step in the treatment of neurodegenerative disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2013.778242

Multifunctional ligands in medicinal inorganic chemistry--current trends and future directions

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2013.778242

Safety and efficacy of fasudil monotherapy and fasudil-ozagrel combination therapy in patients with subarachnoid hemorrhage: sub-analysis of the post-marketing surveillance study

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2013.778242

Simvastatin improves clinical scores in a rabbit multiple infarct ischemic stroke model: synergism with a ROCK inhibitor but not the thrombolytic tissue plasminogen activator

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2013.778242

A Rho kinase (ROCK) inhibitor, fasudil, prevents matrix metalloproteinase-9-related hemorrhagic transformation in mice treated with tissue plasminogen activator.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2013.778242

Beneficial effects of a combination of Rho-kinase inhibitor and ACE inhibitor on tubulointerstitial fibrosis induced by unilateral ureteral obstruction

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2013.778242

10.1517/13543784.2013.778242

21 January 2018

Identifiers

DOI

1 reference

28 August 2017

1 reference